The Japan Clinical Trials Market is on an upward trajectory, poised to reach a remarkable market size of USD 3.6 billion by 2035, with a compound annual growth rate (CAGR) of 4.42%. This growth reflects a broader transformation within the healthcare sector, driven by advancements in technology and a robust regulatory framework. The market, valued at USD 1.52 billion in 2024, is expected to...